Nepexto®

ACTIVE PRINCIPLE:
etanercept

INDICATION:
Rheumatoid Arthritis
Juvenile rheumatoid arthritis
Psoriasic arthritis
spondyloarthropathies
Ankylosing spondylitis
Psoriasis

DATE:
20/05/2020

STATUS:
Authorized

MORE INFORMATION